Worsening of osteomalacia in a patient successfully treated for neuro-Behçet's disease with infliximab.
Madanat
W Y
WY
Madanat
A Y
AY
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy*; D001927:Brain Diseases / Q000150:complications / Q000188:drug therapy*; D001933:Brain Stem / Q000473:pathology; D003078:Colchicine / Q000009:adverse effects; D005260:Female; D006074:Gout Suppressants / Q000009:adverse effects; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D010018:Osteomalacia / Q000139:chemically induced / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D006074:Gout Suppressants; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D003078:Colchicine